Drugs / Sacubitril / Valsartan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05117736 | Mar 2022 → Mar 2023 | congenital heart malformation, heart failure | Montreal Heart Institute | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sacubitril / Valsartan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05117736 ↗ |
| Route | Oral | “Sacubitril / Valsartan Oral Tablet” NCT05117736 ↗ |